The Federal Circuit vacated PTAB rulings because the Board required a skilled artisan personally to fabricate a claimed integrated circuit.
The Federal Circuit affirmed because an IPR petition’s headings did not substitute for developed obviousness arguments for each challenged claim.
The Federal Circuit vacated noninfringement summary judgment because ambiguous prosecution statements were not a clear disclaimer.
The Federal Circuit affirmed PTAB obviousness rulings based on archived evidence of an arXiv publication and qualified machine-learning testimony.
The Federal Circuit affirmed that challenged inkjet-printhead patent claims were obvious over a combination of prior-art references.
Federal Circuit affirms PTAB finding that claims in Woodway’s curved-running-belt manual treadmill patent are obvious over 1970s–1990s prior art, rejecting narrow claim construction and commercial success arguments.
The Supreme Court of Canada rules 7-2 that methods of medical treatment remain unpatentable in Canada, but upholds Janssen’s dosing-regimen patent for INVEGA SUSTENNA because the specific schedule does not require professional medical judgment to implement.
A federal jury in Waco, Texas awards Viasat $229 million in damages after finding Kioxia’s NAND flash memory products infringed U.S. Patent No. 8,615,700, covering forward error correction with parallel detection for flash memories.
The Federal Circuit affirmed two PTAB inter partes review decisions invalidating all claims of Slingshot Printing’s inkjet-printer temperature-sensor patents as obvious over a combination of prior art references.
The ITC institutes Investigation No. 337-TA-1511 against Samsung, Google, NVIDIA, Broadcom, and Supermicro based on Netlist’s HBM and DDR5 memory patents, seeking exclusion orders that could disrupt AI hardware supply chains.
The Second Circuit affirmed an arbitral award giving Acorda only $16.5M of the ~$82M in post-expiration royalties it paid on an Ampyra MS drug patent, holding Brulotte/Kimble do not mandate full restitution and that New York’s Voluntary-Pay Doctrine bars recovery of royalties paid without contemporaneous protest.
The Federal Circuit affirmed three PTAB decisions preserving CPC Patent Technologies’ biometric smart-lock patents, holding that ASSA ABLOY failed to prove obviousness under its own proposed claim construction and forfeited a Bianco-only invalidity theory by raising it too late.
The Federal Circuit vacated a PTAB decision upholding Parus Holdings’ voice-browsing patent against Google’s IPR challenge, holding that the Board improperly analyzed prior art in isolation rather than in combination, secretly construed a claim term without notice to Google, and failed to explain its inconsistency with earlier IPR rulings on related Parus patents.
The Federal Circuit reversed a preliminary injunction in a patent dispute over insulated truck cargo doors, holding that the accused ‘sandwich’ panel door raised substantial questions of non-infringement under three separate claim limitations and that the patentee failed to show irreparable harm.
A Western District of Texas judge ruled that LzLabs GmbH’s Software Defined Mainframe technology infringes five IBM patents covering mainframe instruction translation and emulation techniques, handing IBM a significant win in its effort to protect the proprietary architecture underpinning its multi-billion-dollar mainframe franchise.
A Northern District of California judge awarded Netflix $3 million in attorney fees after finding that plaintiff Lauri Valjakka and his counsel committed fraud by asserting ownership of U.S. Patent No. 8,495,167 while concealing a Finnish court’s prior determination that Valjakka did not own the patent — rendering the entire suit objectively baseless from its inception.
The Federal Circuit affirmed PTAB’s finding that cloud-gaming method claims were obvious over prior art—while clarifying the scope of the mandate rule and confirming that a tribunal on remand may reach claim limitations left unaddressed in the original appeal.
The Federal Circuit affirmed the PTAB’s ex parte reexamination finding that claim 1 of Magnolia’s blood sequestration device patent is anticipated by a 1999 Brannon prior art reference, rejecting Magnolia’s arguments about timing and configuration requirements.
The Federal Circuit affirmed invalidity of Wyeth’s lung cancer treatment patents after holding that the specifications failed to enable skilled artisans to determine an appropriate daily dosage for patients without undue experimentation, erasing a $107.5 million jury verdict.
Judge Thomas Kleeh dismissed Amgen’s Walker Process antitrust counterclaims in Regeneron’s patent suit over Eylea biosimilars, finding Amgen failed to plausibly allege that Regeneron knowingly made false statements to the USPTO to obtain its blocking patent.
A Western District of Texas jury delivered a split verdict against Align Technology in its Invisalign patent suit against ClearCorrect, finding all four asserted patents on multilayer dental aligners infringed but invalid—leaving Align without patent protection against its largest clear-aligner competitor.
The U.S. ITC’s limited exclusion order against Innoscience’s legacy GaN semiconductor products became final on July 7, 2026 after the Presidential Review Period expired without intervention — though Innoscience’s current product line, redesigned to avoid the ‘481 patent, remains freely importable.
A California federal judge dismissed a seven-year patent infringement lawsuit against E. & J. Gallo Winery, finding that the winery’s irrigation systems do not satisfy the scope of the asserted patents on vineyard monitoring technology.
The Patent Trial and Appeal Board cancels all eight claims of Intellectual Ventures’ U.S. Patent 11,664,889, which covers TD-CDMA closed-loop power control in 3G wireless networks, finding them unpatentable over prior art combinations led by the Dateki reference.
A Manhattan federal judge permanently dismisses Loyal-T Systems’ patent infringement suit against American Express, ruling that the accused Membership Rewards and Plenti loyalty programs do not infringe patents requiring a loyalty platform “separate and apart” from a payment card.
Magistrate Judge Payne issued three pre-trial Daubert orders in Smart RF’s patent suit against AT&T, Verizon, and T-Mobile, allowing a damages expert’s comparable-license methodology to stand while partially excluding an invalidity expert for untimely disclosures.
In a sweeping pretrial conference order, Judge Rodney Gilstrap ruled on 23 contested motions in Stratasys’s 3D-printing patent case against Bambu Lab — letting most patents advance to trial while striking key portions of Stratasys’s damages theory.
The Federal Circuit vacated a district court ruling that two “executable program code” limitations in TrackTime’s audio-synchronization patents were means-plus-function terms, remanding for fresh analysis under the intervening Dyfan precedent, while affirming invalidity of a related patent claim for anticipation.
The Federal Circuit affirmed that “mounted on” in a video laryngoscope patent means fastened to the exterior of the blade — not merely positioned inside with an exposed lens — ending a 16-year patent infringement battle.
A Colorado federal judge grants Amgen a preliminary injunction blocking the state’s first-in-the-nation Enbrel price cap, finding that capping the price of a patented drug is not a permissible option for states under federal patent law.
A Western District of Washington court denied Zillow’s motion to dismiss IBM’s single sign-on authentication patent claim (U.S. Patent No. 7,631,346), sending the case toward trial and potentially exposing platforms using federated login to similar claims.
A split Federal Circuit affirms the patent claim construction that kept a generic Nuedexta competitor off the market, but vacates the bond waiver and orders the district court to set a proper security amount.
A Delaware federal court held that HP, Dell, and ASUS acquired implied licenses to LiTL’s portable computer patents through a component supplier’s express license, granting summary judgment for the laptop makers under the legal estoppel doctrine.
A Delaware court ruled that HP, Dell, and ASUS hold implied patent licenses through their unnamed component supplier’s settlement with LiTL LLC, granting summary judgment of noninfringement on all six asserted portable-computer design patents.
The Patent Trial and Appeal Board issued a split final written decision in a pair of inter partes review proceedings filed by ResMed Corp., finding one Cleveland Medical Devices sleep apnea treatment patent unpatentable while upholding claims in a closely related companion patent, illustrating the all-or-nothing stakes of IPR litigation on patent families.
The U.S. International Trade Commission instituted Investigation No. 337-TA-1508 on a complaint by Seer, Inc. and Brigham and Women’s Hospital against Chinese proteomics company Nanomics Biotechnology, alleging infringement of patents covering AI-enabled protein analysis systems and seeking an exclusion order on Nanomics’ imports.
An Eastern District of Texas jury awarded Vasu Holdings $3 million after finding Samsung’s Galaxy smartphones infringed a wireless roaming patent, while clearing Samsung on two other asserted patents.
A Delaware federal judge found that supplement maker Elysium Health failed to prove inequitable conduct or unclean hands by W.R. Grace in connection with nicotinamide riboside patents — leaving intact a $3.6 million willful infringement verdict.
A PTAB leadership panel on June 26, 2026 reversed the Board’s earlier cancellation of an Express Mobile website-building patent, holding that PTAB should not reach a different validity outcome than the jury when both forums consider the same evidence — a ruling with broad implications for GoDaddy’s $253M exposure.
The D.C. Circuit held that a generic drugmaker cannot escape a Hatch-Waxman patent judgment by amending its drug application — the bar on FDA approval runs to the application number itself, not to any particular labeled indication.
The U.S. International Trade Commission issued a final determination that Voltage LLC violated Section 337 by importing solar trunk bus cable assemblies that infringe two Shoals Technologies patents, imposing a limited exclusion order and 100% bond during presidential review.
The PTAB held that a child patent in a continuation family is not invalid for obviousness-type double patenting (ODP) if its expiration date does not exceed the original patent’s expiration date — including any patent term adjustment (PTA) — providing important clarity for continuation patent strategy.
Mr. Justice Meade ordered Warner Bros. Discovery and Paramount to make interim RAND payments to Nokia for video streaming codec standard-essential patents, finding that the Nokia Lump Sum Offer was the most credible interim payment benchmark, while discounting Nokia’s claim to full royalties going back to 2011 due to its late-arriving licensing programme.
The Federal Circuit affirmed Intel’s summary judgment win, finding PACT XPP forfeited its capability-based infringement theory on the ‘301 patent and that prosecution statements during ex parte reexamination narrowed the ‘593 patent’s ‘physically dedicated connection’ claim to exclude Intel’s shared-bus architecture.
The Fourth Circuit affirmed that Sophos’s post-acquisition antivirus products were not “derivations” of the named containerization products in a 2016 patent license agreement, even though they shared some common source code, because the shared code was inactive in the original products and the newer products did not originate from them.
USPTO Director John Squires vacated a PTAB panel’s obviousness finding on U.S. Patent No. 11,828,425, ruling the Board failed to explain why its conclusion on claim 2 differed from a jury verdict finding the same claim valid and infringed — reinforcing the September 2025 PTAB parallel-proceedings memorandum.
The Federal Circuit affirmed invalidation of Enanta’s Paxlovid-related patent because its 2020 provisional application disclosed ‘C2’ alkyl groups while the issued patent claimed ‘C1,’ a difference of one carbon atom that broke the priority chain and exposed the claims to anticipation by Pfizer’s prior disclosure of nirmatrelvir.
USPTO Director Squires issued a precedential decision vacating three IPR institution grants after a federal court found all challenged Lightning Roulette patents invalid under § 101, while simultaneously establishing a new 30-day deadline for parties to request Director Review of institution decisions.
The UPC Düsseldorf Local Division rules that Article 72 UPCA’s five-year limitation period covers only financial compensation — not injunctions — confirming that patent holders face no time bar on seeking pan-European injunctive relief regardless of when infringement was discovered.
A federal jury in the Eastern District of Texas awarded Aspen Networks $190 million, finding that Verizon Wireless infringed U.S. Patent No. 8,009,554 covering the core technology enabling seamless Wi-Fi/cellular call handoff (VoWi-Fi).